| Name | Title | Contact Details |
|---|
Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the subject of more than 300 publications. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking.
Zitter Health Insights is a market-leading business intelligence firm serving life science companies, specialty pharmacies and managed healthcare organizations focused on optimizing patient access to pharmaceuticals. The company offers the nation`s largest payer research panel and the largest database of prior authorization policies. The average panel member represents 1 million+ covered lives and the research portfolio covers the entire spectrum of payer-influenced entities. Insights are generated primarily in multi-client subscription formats including: Managed Care Oncology Index, Managed Care Biologics and Injectables Index, Managed Care Benefit Design Index, Prior Authorization Tracking Tool, Managed Care Message Monitor, Co-Pay Offset Monitor, and P&T Perspective. Analysis is conducted for more than 250 manufacturers, 150 therapeutic areas and 1,000 products.
MedCost LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winston Salem, NC. To find more information about MedCost LLC, please visit www.medcost.com
National Healthcare Review is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CCT is a pioneer in the QTc field. We conducted our first study in 1998 with Pfizer's ziprasidone in patients with schizophrenia. Our staff includes experienced principal investigators, dedicated cardiologists, psychiatrists, experienced ECG